@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RAfEzcpj5l5_dHjvqmxFZLVzxFezE9EEV6_3ZnAKGV1WE#> .
@prefix this: <http://purl.org/np/RAfEzcpj5l5_dHjvqmxFZLVzxFezE9EEV6_3ZnAKGV1WE> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  rdf:OBJECT rdfs:label "treatment success or failure" .
  
  rdf:OBJECT-POSITION rdfs:label "(288, 301)" .
  
  rdf:PREDICATE rdfs:label "assess" .
  
  rdf:SUBJECT rdfs:label "a control group" .
  
  rdf:SUBJECT-POSITION rdfs:label "(288, 301)" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0009932> ns1:assess <https://uts.nlm.nih.gov/uts/umls/concept/C0679864>;
    rdfs:label "control group" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0679864> rdfs:label "treatment success" .
}

sub:provenance {
  sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" .
  
  sub:assertion prov:generatedAtTime "2023-06-12T11:58:36.528122"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0003-4692-1377 .
  
  rdf:Statement rdfs:label "Baseline Characteristics by Respiratory Status Pre-Tocilizumab Administration [Image: see text] Subgroup Analysis [Image: see text] Outcome by Baseline IL-6 Levels [Image: see text] Overall mortality in our patients was 43%; however, our's sample size was small and this analysis did not have a control group to fully assess treatment success or failure." .
  
  rdfs:ABSTRACT-UID rdfs:label "bnp8ln4c" .
  
  rdfs:TRIPLE-UID rdfs:label "bnp8ln4c-TRIPLE-ABSTRACT-8" .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "c3NoLXJzYSBBQUFBQjNOemFDMXljMkVBQUFBREFRQUJBQUFCZ1FDZERUMW1DbmR0T21pNm16VDhyMmI2QVRYZ0I0d1ExWTZUU3NtN2xNblVLWll0REpuSHkzRnI3YjJJUytJZkRBRmxTYVJFbkR4bnJFNWF0QUw0TzdlZ0RrUDlqSHBaNUJlWFhhL1RMOUFKVzRKVVlSRm1OZER3am4xMndsNWVFK20wUkFZanpzejZtQzd4bER6aEFvY2Rrb2VCWXJzbUZZTlVRaUVNdmtNSXY5SU5nNVgzeTU0VWJzVTRwTzExclpNekpocm15ajVhZkE5bmd5ZnBFR0dJc0hTQzJyekRrb2VtVDZXZitVeTBQVHFSbGZGWk1jbG5iMC9CZ2t4Qk9ydVJacm85WFNOMWhFWDNQNTNsSGlGZld6UGExVDZBYjZXaXl4RTF5djNldHlPbXRkN2VWZ2I1eFpOYjNFekhKNFpmN1AvYVB2dVFFdGJzY2NkODJMNzAwSTZPMFdLUDVIVTNrQ01iYXczOVJONGZYYWkyMVdPK2NwODFCV2VvQWk4Yzd2OXQvZTdnYWNKYmJmVFNBQjhZeWs5T0QwWm5OM3ZaRW1TSHMxTTdhVk5QTjhVM3o4d095NEtXYVVRK0FkN1JIMnBDa0NZSk42YUcwL3VPS3d1VXB1NDVIN3FJWUJOSWxpTFRRN2U5a2Y0cWhBYVZ1SEhzc0x6cU1QSmpkYkU9IGF0d2lsdEBMQVBUT1AtRjNMTFJCS1IK";
    npx:hasSignature "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";
    npx:hasSignatureTarget this: .
  
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}